Life-Saving Discrepancy: Study Shows Effectiveness Of Mismatched Bone Marrow Transplants

October 22, 1998

REHOVOT, Israel -- October 22, 1998 -- For many leukemia sufferers, bone marrow transplantation is their only hope. Unfortunately, in about 40 percent of terminal cases, patients fail to find a perfectly matched donor among relatives or in any of the donor registries.

Now, scientists from Israel's Weizmann Institute of Science and Perugia University in Italy have shown that thanks to a method they developed, transplants using mismatched marrow can be as effective as those in which the donor and recipient are fully matched. The results of their latest study, reported in the October 22 issue of the NEW ENGLAND JOURNAL OF MEDICINE, have raised hopes that one day a donor will be found for virtually every candidate for a bone marrow transplant.

Normally, a donor and recipient are considered compatible when they are matched for all six immunological markers on their chromosomes - three inherited from the mother and three from the father. In the method developed by a team headed by Prof. Yair Reisner of Weizmann's Immunology Department and Prof. Massimo Martelli of Perugia's Policlinico Monteluce, the donor and the recipient need to be matched for only three markers.

Such a partial match is always found between parents and children, and there is a 75-percent chance of finding it between siblings. Even among the extended family, the chances of finding a partially compatible donor are fairly good. A key element of the Weizmann-Perugia method is the use of extremely large doses of donor marrow that literally overwhelm the recipient's rejection mechanism. The donor is treated with hormone injections that release large numbers of stem cells from the bone marrow into the bloodstream. In a procedure known as leukapheresis, the stem cells are selectively removed from blood withdrawn from the body, and the remaining blood is re-infused into the donor.

In another crucial step, donated stem cells are then "cleansed" to erase the characteristics that contribute to rejection in mismatched transplants.

In the study, the Perugia-Weizmann team traces the results of dozens of such mismatched transplants performed on patients with high-risk acute myeloid leukemia or acute lymphoid leukemia between 1995 and 1997.

Of the 43 patients treated, 12 (28 percent) were free of disease when the study results were summed up, 8 to 30 months after transplantation (a median follow-up of 18 months). To appreciate this figure, one must keep in mind that all patients had failed to respond to any other treatment, and without a transplant would have certainly died. The rest of the patients were alive but had a relapse of leukemia, or had died of the disease or of transplant-related complications.

These results are similar to the success rate obtained in this category of patients with perfectly matched transplants from unrelated donors.

According to the scientists, the study shows that their method overcomes the main obstacles limiting the use of mismatched transplants -- namely, graft failure and an adverse immunological reaction called graft-versus-host disease.

"Since most patients have a mismatched relative [who can serve as a bone marrow donor], advances in this area will greatly increase the availability of transplants as curative therapy," the researchers conclude in their report.'<>p> Several hospitals in Israel, Germany, Austria and the United States have begun to introduce the Perugia-Weizmann transplantation method.

Prof. Reisner holds the Henry H. Drake Professorial Chair in Immunology at the Weizmann Institute. This research was funded in part by Rowland Schaefer, Miami, Florida; the Pauline Fried Estate, Los Angeles, California; the Concern Foundation, Los Angeles, California; the Israel Academy of Sciences and Humanities; Comitato per la Vita "Daniele Chianelli"; Associazione Italiana Ricerche sul Cancro (AIRC); Associazione Italiana Leucemie e Linfomi (AIL), and Istituto Superiore di Sanita, Italy-USA Program on Therapy of Tumors.
Luba Vikhanski
Head, Foreign Press Section
Publications and Media Relations Department
Weizmann Institute of Science, Rehovot 76100, Israel
Tel. 972-8-934-3855 (office) 972-3-602-2868 (home)
Fax 972-8-934-4104
Have you visited our Web site?

American Committee for the Weizmann Institute of Science

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to